Natriuretic peptides receptors in human aldosterone-secreting adenomas

Journal of Endocrinological Investigation

Volumn 22, Issue 7, 1999, Pages 514-518

  Sarzani, Riccardo ^a,c   Opocher, G ^b   Paci, M V ^a   Belloni, A S ^b   Mantero, F ^a   Dessi Fulgheri P ^a   Rappelli, A ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Azienda Ospedaliera Umberto I   (Italy)

Author keywords

Adenoma; Aldosterone; Human adrenal; Natriuretic peptide receptors

Indexed keywords

ALDOSTERONE; ATRIAL NATRIURETIC FACTOR RECEPTOR; BRAIN NATRIURETIC PEPTIDE; COMPLEMENTARY DNA; IODINE 125; MESSENGER RNA; NATRIURETIC PEPTIDE TYPE C; RECEPTOR;

ADENOMA; ALDOSTERONE RELEASE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITY; HUMAN; HUMAN TISSUE; MESSENGER RNA SYNTHESIS; MOLECULAR CLONING; NORTHERN BLOTTING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATIC MUTATION;

EID: 0032832558     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343602     Document Type: Article

References (30)

1. Higuchi K, Nawata H, Kato K, Ibayashi H, Matsuo H. a-human atrial natriuretic polypeptide inhibits steroidogenesis in cultured human adrenal cells. J. Clin. Endocrinol. Metab. 1986, 62: 941-944.
2. Anderson J.V., Struthers A.D., Payne N.N., Slater J.D., Bloom S.R. Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man. Clin. Sci. 1986, 70: 507-12.
3. Williams T.D.M., Walsh K.P., Lightman S.L., Sutton R. Atrial natriuretic peptide inhibits postural release of renin and vasopressin in humans. Am. J. Physiol. 1988, 255: R368-72.
4. Holmes S.J., Espiner E.A., Richards A.M., Yandle T.G., Frampton C. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal men. J. Clin. Endocrinol. Metab. 1993, 76: 91-96.
5. Nawata H., Ohashi M., Haji M., Takayanagi R., Higuchi K., Fujio N., Hashiguchi T., Ogo A., Nakao R., Ohnaka K. Atrial and brain natriuretic peptide in adrenal steroidogenesis. J. Steroid. Biochem. Mol. Biol. 1991, 40: 376-379.
6. nd ed. Raven Press, New York, 1995, 1001-1019.
7. Mantyh C.R., Kruger L., Brecha N.C., Mantyh P.W. Localization of specific binding sites for atrial natriuretic factor in peripheral tissues of the guinea pig, rat, and human. Hypertension 1986, 8: 712-721.
8. Meloche S., Ong H., Cantin M., De Lean A. Affinity cross-linking of atrial natriuretic factor to its receptor in bovine adrenal zona glomerulosa. J. Biol. Chem. 1986, 261: 1525-1528.
9. Yamaji T., Ishibashi M., Sekihara H. Plasma level of atrial natriuretic peptide in primary aldosteronism and essential hypertension. J. Clin. Endocrinol. Metab. 1986, 63: 815-818.
10. Opocher G., Rocco S., Carpené G., Vettoretti A, Cimolato M, Mantero F. Usefulness of atrial natriuretic peptide assay in primary aldosteronism. Am. J. Hypertens. 1992, 5: 811-816.
11. Mukoyama M., Nakao K., Saito Y., Ogawa Y., Hosoda K., Suga S., Shirakami G., Jougasaki M., Imura H. Human brain natriuretic peptide, a novel cardiac hormone. Lancet 1990, 335: 801-802.
12. Higuchi K., Nawata H., Kato K., Ibayashi H., Matsuo H. Lack of inhibitory effect of a-human atrial natriuretic polypeptide on aldosteronogenesis in aldosterone-producing adenoma. J. Clin. Endocrinol. Metab. 1986, 63: 192-196.
13. Rocco S., Opocher G., D'Agostino, Leone L., Mantero F. Lack of aldosterone inhibition by atrial natriuretic factor in primary aldosteronism: in vitro studies. J. Endocrinol. Invest. 1989, 72: 13-17.
14. Rocco S., Opocher G., Carpené G., Mantero F. Atrial natriuretic peptide infusion in primary aldosteronism. Renal, hemodynamic and hormonal effects. Am. J. Hypertens. 1990, 3: 668-673.
15. Sarzani R., Dessì-Fulgheri P., Paci V.M., Espinosa E., Rappelli A. Expression of natriuretic peptide receptors in human adipose and other tissues. J. Endocrinol. Invest. 1996, 19: 581-585.
16. Lowe D.G., Camerato T.R., Goeddel D.V. cDNA sequence of the human atrial natriuretic peptide clearance receptor. Nucleic Acids Res. 1990, 78: 3412.
17. Chang M-s, Lowe D.G., Lewis M., Hellmiss R., Chen E., Goeddel D.V. Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature 1989, 341: 68-72.
18. Lowe D.G., Chang M.-S., Hellmiss R., Chen E., Singh S., Garbers D.L., Goeddel D.V. Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction. Embo J. 1989, 8: 1377-1384.
19. Porter J.G., Arfsten A., Fuller F., Miller J.A., Gregory L.C., Lewicki J.A. Isolation and functional expression of the human atrial natriuretic peptide clearance receptor cDNA. Biochem. Biophys. Res. Commun. 1990, 177: 796-803.
20. Sarzani R., Paci V.M., Dessì-Fulgheri P., Espinosa E., Rappelli A. Comparative analysis of atrial natriuretic peptide receptor expression in rat tissues. J. Hypertens. 1993, 11 (Suppl. 5): S214-S215.
21. Sarzani R., Fallo F., Dessì-Fulgheri P., Pistorello M., Lanari A., Paci V. M., Mantero F., Rappelli A. Local renin-angiotensin system in human adrenals and aldosteronomas. Hypertension 1992, 19: 702-707.
22. Herkenham M., Pert C.B. Light microscopic localization of brain opiate receptors: a general autoradiographic method which preserves tissue quality. J. Neurosci. 1982 2: 1129-1149.
23. Oda S., Sano T., Morishita Y., Matsuda Y. Pharmacological profile of HS-141-1, a novel non-peptide atrial natriuretic peptide (ANP) antagonist of microbial origin. II. Restoration by HS-142-1 of ANP-induced inhibition of aldosterone production in adrenal glomerulosa cells. J. Pharmacol. Exp. Ther. 1992, 263: 241-245.
24. Olson L.J., Lowe D.G., Drewett J.C. Novel natriuretic peptide receptor/guanylyl cyclase A-selective agonist inhibits angiotensin II-and forskolin-evoked aldosterone synthesis in a human zona glomerulosa cell line. Mol. Pharmacol. 1966, 50: 430-435.
25. Bodart V., Rainey W.E., Foumier A., Ong H., De Lean A. The H295R human adrenocortical cell line contains functional atrial natriuretic peptide receptors that inhibit aldosterone biosynthesis. Mol. Cell. Endocrinol. 1996, 118: 137-144.
26. Shionoiri H., Hirava N., Takasaki I., Ishikawa Y., Oda H., Gotoh E., Hosaka M., Shimonaka M., Ishido M., Hirose S. Lack of atrial natriuretic peptide receptors in human aldosteronoma. Biochem. Biophys. Res. Commun. 1988, 152: 37-43.
27. Rebuffat P., Mazzocchi G., Gottardo G., Meneghelli V., Nussdorfer G.G. Further investigation on the atrial natriuretic factor (ANF)-induced inhibition of the growth and steroidogenic capacity of rat adrenal zona glomerulosa in vivo. J. Steroid. Biochem. 1988, 29: 605-609.
28. Sarzani R., Opocher G., Dessl-Fulgheri P., Paci V.M., Cola G., Rocco S., Vianello B., Mantero F., Rappelli A. Expression of type 1 angiotensin II receptors in human aldosteronomas. Endocr. Res. 1995, 21: 189-195.
29. Kawai M., Naruse M., Yoshimoto T., Naruse K., Shionoya K., Tanaka M., Morishita Y., Matsuda Y., Demura R., Demura H. C-type natriuretic peptide as possible local modulator of aldosterone secretion in bovine adrenal zona glomerulosa. Endocrinology 1996, 137: 42-46.
30. Grandclement B., Ronsin B., Morel G. The three subtypes of atrial natriuretic peptide (ANP) receptors are expressed in the rat adrenal gland. Biol. Cell 1997, 89: 29-41.